Diversity & Inclusion in Clinical Trials

Booking Link: click here to book

Description of event:

Our next PCMG Insights session will take place in November, focusing on the vital topic of Diversity & Inclusion in Clinical Trials.

When reviewing your outsourcing plan or strategy, have you included the voice of your patients?

This PCMG Insights session, hosted by the PCMG Sustainability Action Group, explores how Diversity & Inclusion (D&I) can be embedded into the clinical development outsourcing process — from protocol design and patient recruitment through to vendor governance and contracting.

The discussion will examine:

• The importance of diverse and inclusive clinical trials
• How service providers can help address “D&I gap management” through inclusive protocols and patient engagement strategies
• The impact of regulations such as GDPR on patient data and representation
• Best practices for incorporating D&I principles into service provider relationships and contracts

Featuring experts from across industry, the panel will share practical examples and strategies to help sponsors and CROs work together to achieve fair representation, ethical recruitment, and sustainable inclusion practices in global trials.

Confirmed speakers include Dr. Susan Tio, Senior Director, Europe Region Lead Diversity and Inclusion in Clinical Trials at Sanofi, who brings over 30 years of experience in clinical development, operations, and leadership roles across multiple pharmaceutical organisations. She also chairs the Pharma.be Clinical Trials Taskforce and is actively driving initiatives to improve fair representation of diverse populations in research.

Jo Humphrey will also speak in the session, Senior Clinical Contract Specialist, Reckitt. She is passionate about challenging the status quo in clinical outsourcing and shaping more agile, transparent, and collaborative approaches to research partnerships. I believe we can move beyond “business as usual” to create smarter models that truly support innovation.

The session will be chaired by Sandra Johnson, an experienced outsourcing and sustainability leader based in Switzerland. With over 20 years of experience in project management and a passion for collaborative, effective teams, Sandra will guide an open discussion on practical, real-world approaches to achieving meaningful inclusion in outsourced clinical research.

Whether you’re shaping outsourcing strategies, overseeing vendor partnerships, or designing patient engagement frameworks, this session will provide actionable insights into aligning operational excellence with inclusive, patient-centered trial delivery.